U.S. Withdraws from UNESCO

The decision to leave the United Nations’ educational, scientific, and cultural agency was spurred by what American officials say is the organization’s anti-Israel bias and lack of commitment to reform.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, CANCILLERIA ECUADORThe United States has announced its intention to withdraw from the United Nations Educational, Scientific and Cultural Organization (UNESCO). According to the State Department, following the withdrawal, effective on December 31, 2018, the U.S. will take on a role as an “observer state” to provide expertise as a non-member.

“This decision was not taken lightly,” State Department spokeswoman Heather Nauert says in a statement. The move “reflects U.S. concerns with mounting arrears at UNESCO, the need for fundamental reform in the organization, and continuing anti-Israel bias at UNESCO.”

Among the organization’s better-known roles is its designation of World Heritage sites to highlight areas of important cultural or scientific value. Sites considered of global biological importance include Australia’s Great Barrier Reef and Ecuador’s Galapagos Islands. The organization also plays host to major international programs in basic research, education, and science policy.

It’s not the first time that the U.S. has pulled out of UNESCO since the organization’s founding following the end of World War II. In 1984, then-President Ronald Reagan withdrew on the grounds of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide